ATE350662T1 - Markerproteine für prostatakrebs - Google Patents

Markerproteine für prostatakrebs

Info

Publication number
ATE350662T1
ATE350662T1 AT00968823T AT00968823T ATE350662T1 AT E350662 T1 ATE350662 T1 AT E350662T1 AT 00968823 T AT00968823 T AT 00968823T AT 00968823 T AT00968823 T AT 00968823T AT E350662 T1 ATE350662 T1 AT E350662T1
Authority
AT
Austria
Prior art keywords
prostate cancer
marker proteins
patients
subjects
prostate
Prior art date
Application number
AT00968823T
Other languages
English (en)
Inventor
Tai-Tung Yip
Christine Yip
George L Wright Jr
Original Assignee
Ciphergen Biosystems Inc
Eastern Virginia Med School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22568045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE350662(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciphergen Biosystems Inc, Eastern Virginia Med School filed Critical Ciphergen Biosystems Inc
Application granted granted Critical
Publication of ATE350662T1 publication Critical patent/ATE350662T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00968823T 1999-10-07 2000-10-06 Markerproteine für prostatakrebs ATE350662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15842299P 1999-10-07 1999-10-07

Publications (1)

Publication Number Publication Date
ATE350662T1 true ATE350662T1 (de) 2007-01-15

Family

ID=22568045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968823T ATE350662T1 (de) 1999-10-07 2000-10-06 Markerproteine für prostatakrebs

Country Status (7)

Country Link
EP (1) EP1224466B1 (de)
JP (1) JP2004500553A (de)
AT (1) ATE350662T1 (de)
AU (1) AU7868300A (de)
CA (1) CA2386669A1 (de)
DE (1) DE60032784T2 (de)
WO (1) WO2001025791A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1426536A (zh) * 2000-03-20 2003-06-25 东弗吉尼亚医学院 前列腺癌标记
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
US20060088830A1 (en) * 2002-02-21 2006-04-27 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
AU2003274368B2 (en) 2002-10-30 2008-11-20 Proteome Sciences Plc. Diagnostic method for transmissible spongiform encephalopathies (prion diseases)
AU2003296086A1 (en) 2002-12-26 2004-07-22 Nitto Boseki Co., Ltd. Immunoassay method and kit to be used therein
EP1613966A2 (de) 2003-04-08 2006-01-11 Colotech A/S Verfahren zum nachweis von kolorektalem krebs in menschlichen proben
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP4568551B2 (ja) * 2004-07-28 2010-10-27 一晃 掛樋 糖たん白質糖鎖の分析方法及び非標識糖鎖の製造方法
US20090298184A1 (en) * 2005-04-07 2009-12-03 Harald Mischak Polypeptide Markers for the Diagnosis of Prostate Cancer
WO2007109881A1 (en) * 2006-03-24 2007-10-04 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2012127A3 (de) * 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnosemarkierungen zur Erkennung von Prostatakrebs
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
JP2013528379A (ja) * 2010-05-21 2013-07-11 オームクス コーポレーション Ｐｓａ酵素活性アッセイによる癌の検出
CA2835806A1 (en) 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity
EP3047274A2 (de) * 2013-09-20 2016-07-27 Ohmx Corporation Psa-enzymaktivität: neuer biomarker zur bestimmung der aggressivität von prostatakrebs
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
WO1998040738A1 (en) * 1997-03-11 1998-09-17 Sloan Kettering Institute For Cancer Research Prostate specific antigen substrates
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6300088B1 (en) * 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
EP1047793B1 (de) * 1998-01-21 2006-11-15 Dianon Systems, Inc. Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
EP1080194A2 (de) * 1998-05-29 2001-03-07 Incyte Pharmaceuticals, Inc. Humane transmembranproteine

Also Published As

Publication number Publication date
DE60032784T2 (de) 2007-11-08
AU7868300A (en) 2001-05-10
EP1224466B1 (de) 2007-01-03
WO2001025791A2 (en) 2001-04-12
DE60032784D1 (de) 2007-02-15
EP1224466A2 (de) 2002-07-24
JP2004500553A (ja) 2004-01-08
WO2001025791A3 (en) 2001-12-27
CA2386669A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
ATE350662T1 (de) Markerproteine für prostatakrebs
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
ATE194660T1 (de) Veraendertes gen bei menschlichem colorektalem- krebs
DE69907156D1 (de) Krebsbehandlung
WO1997036535A3 (en) Biomarkers for detection, diagnosis and prognosis of prostate cancer
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
BR0316111A (pt) Métodos para diagnosticar rcc e outros tumores sólidos
DE69933989D1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
YU61701A (sh) Postupak i kit za efikasno radioobeležavanje proteina sa terapeutskim radioizotopom
HUP0302332A2 (hu) Génkimutatási eljárás ErbB-antagonistával végzett rákterápiára adott hatékony reakció valószínûségének növelésére
AU9779498A (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
DE60223176D1 (de) Metallkomplexverbindungen
DE60127104D1 (de) Prostatakrebs-marker
IL151448A0 (en) Proteins
WO2001042792A3 (en) Diagnosis of cervical cancer using marker proteins
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
WO2002023200A3 (en) Human breast cancer biomarkers
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
DE60119731D1 (de) Immunologisches test und satz zur diagnose von prostatadenokarzinom
ATE409226T1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
DE69839846D1 (de) Bestimmung der vorhandenen mengen an cyclin-abhängr bei krebspatienten
WO2001096599A3 (en) Methods for quantitative determination of b-fibronectin in biological fluids and tissues
ATE256682T1 (de) Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation
WO2003020294A8 (de) Markierung der aromatase
WO2003043566A3 (en) Hip1 cancer markers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties